×
About 18,614 results

ALLMedicine™ Urinary Tract Infections Center

Research & Reviews  7,335 results

New Perspectives on Antimicrobial Agents: Ceftolozane/tazobactam.
https://doi.org/10.1128/AAC.02318-20
Antimicrobial Agents and Chemotherapy; Lizza BD, Betthauser KD et. al.

Apr 20th, 2021 - Ceftolozane-tazobactam (C/T) is a new fifth-generation cephalosporin/β-lactamase inhibitor combination approved by the Food and Drug Administration and the European Medicines Agency for treatment of complicated intra-abdominal infections, complica...

Lipid-Polymer Hybrid Nanoparticles Enhance the Potency of Ampicillin against Enterococc...
https://doi.org/10.1021/acsinfecdis.0c00774
ACS Infectious Diseases; Tan CH, Jiang L et. al.

Apr 19th, 2021 - Enterococcus faecalis (E. faecalis) biofilms are implicated in endocarditis, urinary tract infections, and biliary tract infections. Coupled with E. faecalis internalization into host cells, this opportunistic pathogen poses great challenges to co...

High Rates of Antibiotic Nonsusceptibility in Gram-negative Urinary Tract Infection in ...
https://doi.org/10.1097/INF.0000000000003147
The Pediatric Infectious Disease Journal; Hain G, Goldbart A et. al.

Apr 19th, 2021 - Choosing an empiric treatment for urinary tract infections (UTIs) requires epidemiologic data on antibiotic nonsusceptibility (ANS) rates, and risk factors for UTI and ANS in the individual patient. We assessed ANS in community-acquired UTI, and i...

Daily inpatient ertapenem therapy can be an alternative to hospitalization for the trea...
https://doi.org/10.1111/ijcp.14230
International Journal of Clinical Practice; Nazli Zeka A, Avkan-Oguz V et. al.

Apr 17th, 2021 - Physicians hospitalize the patients with complicated urinary tract infections (cUTIs) when they need intravenous antibiotics and outpatient parenteral antimicrobial therapy (OPAT) is unavailable. Daily inpatient antimicrobial therapy is an alterna...

Sustained reduction in catheter-associated urinary tract infections using multi-faceted...
https://doi.org/10.1017/ice.2021.135
Infection Control and Hospital Epidemiology; Reynolds SS, Sova CD et. al.

Apr 16th, 2021 - We reviewed the sustainability of a multifaceted intervention on catheter-associated urinary tract infection (CAUTI) in 3 intensive care units. During the 4-year postintervention period, we observed reductions in urine culture rates (from 80.9 to ...

see more →

Guidelines  39 results

ACR Appropriateness Criteria® Recurrent Lower Urinary Tract Infections in Females.
https://doi.org/10.1016/j.jacr.2020.09.003
Journal of the American College of Radiology : JACR; , Venkatesan AM et. al.

Nov 6th, 2020 - Urinary tract infections (UTIs) in women are common, with an overall lifetime risk over >50%. UTIs are considered recurrent when they follow complete clinical resolution of a previous UTI and are usually defined as at least three episodes of infec...

Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study
https://annals.org/aim/article-abstract/2739786/sodium-glucose-cotransporter-2-inhibitors-risk-severe-urinary-tract-infections
Annals of Internal Medicine;

Jul 29th, 2019 - Background: Prior studies evaluating risk for severe urinary tract infections (UTIs) with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have reported conflicting findings. Objective: To assess whether patients initiating use of SGLT-2 inhibi...

FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited ...
https://www.mrknewsroom.com/news-release/prescription-medicine-news/fda-approves-mercks-recarbrio-imipenem-cilastatin-and-releba

Jul 16th, 2019 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved RECARBRIO™ (imipenem, cilastatin, and relebactam) for injection, 1.25 grams, a new combination antib...

Doxycycline: Uses, Side Effects & Dosage Guide - Drugs.com
https://www.drugs.com/doxycycline.html

Jun 30th, 2019 - Doxycycline is an antibiotic used to treat bacterial infections like urinary tract infections, acne and chlamydia. Includes side effects, interactions and indications.

Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline
https://www.auanet.org/guidelines/recurrent-uti

Apr 30th, 2019 - Over the past few decades, our ability to diagnose, treat, and manage recurrent urinary tract infection (rUTI) long-term has evolved due to additional insights into the pathophysiology of rUTI, a new appreciation for the adverse effects of repetit...

see more →

Drugs  1,343 results see all →

Clinicaltrials.gov  9,183 results

New Perspectives on Antimicrobial Agents: Ceftolozane/tazobactam.
https://doi.org/10.1128/AAC.02318-20
Antimicrobial Agents and Chemotherapy; Lizza BD, Betthauser KD et. al.

Apr 20th, 2021 - Ceftolozane-tazobactam (C/T) is a new fifth-generation cephalosporin/β-lactamase inhibitor combination approved by the Food and Drug Administration and the European Medicines Agency for treatment of complicated intra-abdominal infections, complica...

Lipid-Polymer Hybrid Nanoparticles Enhance the Potency of Ampicillin against Enterococc...
https://doi.org/10.1021/acsinfecdis.0c00774
ACS Infectious Diseases; Tan CH, Jiang L et. al.

Apr 19th, 2021 - Enterococcus faecalis (E. faecalis) biofilms are implicated in endocarditis, urinary tract infections, and biliary tract infections. Coupled with E. faecalis internalization into host cells, this opportunistic pathogen poses great challenges to co...

High Rates of Antibiotic Nonsusceptibility in Gram-negative Urinary Tract Infection in ...
https://doi.org/10.1097/INF.0000000000003147
The Pediatric Infectious Disease Journal; Hain G, Goldbart A et. al.

Apr 19th, 2021 - Choosing an empiric treatment for urinary tract infections (UTIs) requires epidemiologic data on antibiotic nonsusceptibility (ANS) rates, and risk factors for UTI and ANS in the individual patient. We assessed ANS in community-acquired UTI, and i...

Daily inpatient ertapenem therapy can be an alternative to hospitalization for the trea...
https://doi.org/10.1111/ijcp.14230
International Journal of Clinical Practice; Nazli Zeka A, Avkan-Oguz V et. al.

Apr 17th, 2021 - Physicians hospitalize the patients with complicated urinary tract infections (cUTIs) when they need intravenous antibiotics and outpatient parenteral antimicrobial therapy (OPAT) is unavailable. Daily inpatient antimicrobial therapy is an alterna...

Sustained reduction in catheter-associated urinary tract infections using multi-faceted...
https://doi.org/10.1017/ice.2021.135
Infection Control and Hospital Epidemiology; Reynolds SS, Sova CD et. al.

Apr 16th, 2021 - We reviewed the sustainability of a multifaceted intervention on catheter-associated urinary tract infection (CAUTI) in 3 intensive care units. During the 4-year postintervention period, we observed reductions in urine culture rates (from 80.9 to ...

see more →

News  689 results

New Guidelines on Antibiotic Prescribing Focus on Shorter Courses
https://www.medscape.com/viewarticle/948754

Apr 4th, 2021 - An antibiotic course of 5 days is usually just as effective as longer courses but with fewer side effects and decreased overall antibiotic exposure for a number of common bacterial conditions, according to new clinical guidelines published today b...

Rural Women Receive Antibiotics for Longer Than Necessary for UTIs
https://www.medscape.com/viewarticle/946963

Mar 4th, 2021 - Women living in rural areas were significantly more likely than were those in urban areas to receive inappropriate antibiotic prescriptions for urinary tract infections, based on data from an observational cohort study of more than 600,000 women. ...

UTI Vaccine in Development Shows Promise
https://www.medscape.com/viewarticle/946728

Mar 1st, 2021 - Although it's still in development, a vaccine against current and future urinary tract infections could also wipe out other problems, such as women being given the wrong antibiotic or given antibiotics for too long, a pair of newly released studie...

Febrile UTIs in Infants: A Talk With the Author of the AAP Guideline
https://www.medscape.com/viewarticle/939185

Nov 29th, 2020 - This transcript has been edited for clarity. Christopher J. Chiu, MD: Welcome. I'm Chris Chiu with The Cribsiders. As always, I'm joined by my co-host, Dr Justin Berk. Justin L. Berk, MD, MPH, MBA: We're here to recap our podcast episode with Kenn...

Postmenopausal Hormone Therapy May Help Protect Against Recurrent UTI
https://www.staging.medscape.com/viewarticle/934357

Jul 21st, 2020 - NEW YORK (Reuters Health) - Older women who take menopausal hormone therapy (MHT) have a greater variety of beneficial bacteria in their urine which may help guard against recurrent urinary tract infections (UTIs), according to research presented ...

see more →

Patient Education  25 results see all →